C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/26 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61P 1/00 (2006.01) A61P 3/00 (2006.01) A61P 7/00 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01) A61P 27/02 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) C07D 401/12 (2006.01) C07D 407/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2748124
Method for treating or preventing a PPAR-responsive condition in a subject, comprising administering to the subject a PPAR agonist that comprises a 8-hydroxyquinoline-methylene-N- group in an amount effective to activate a PPAR polypeptide.
La présente invention concerne un procédé de traitement ou de prévention d'une condition réagissant à PPAR chez un sujet, qui comprend l'administration au sujet d'un agoniste de PPAR qui comprend un groupe 8-hydroxyquinoléine-méthylène-N en une quantité efficace pour activer un polypeptide de PPAR.
Blin Olivier
Champavere Frederic
Kraus Jean-Louis
Biopharmed
Borden Ladner Gervais Llp
LandOfFree
Ppar agonist compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ppar agonist compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ppar agonist compositions and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1681654